Role of Oncogenes and Tumor Suppressors in Metabolic Reprogramming and Cancer Therapeutics: A Review

Journal Title: Journal of Cancer and Tumor International - Year 2016, Vol 4, Issue 4

Abstract

Recently there has been a renewed interest on the signaling pathways and metabolic changes in cancer cells. It is well known that there are several oncogenes and tumor suppressors that affect cancer metabolism and re-engineer it for better growth and survival. The best description of tumor metabolism is the Warburg effect, which shifts from ATP production through oxidative phosphorylation to ATP production through glycolysis, even in the presence of oxygen. The Warburg effect is controlled by oncogenes—c-Myc, Kras, P1K/AKT/mTOR pathway—and tumor suppressors—p53, LKB1/AMPK, PTEN, and RB. Studies on oncogenes and tumor suppressors suggest potential therapeutic strategies. The oncogene Kras promotes increased glucose uptake, glycolytic flux and ribose biogenesis, and mediates reprogramming of glutamine metabolism by changes in gene expression. The tumor suppressor p53 promotes the expression of antioxidant proteins that regulate oxidative stress and glucose metabolism. The LKB1/AMPK agonists have potential to be anticancer drugs, as patients treated by metformin for diabetes had a lower incidence of cancer. Discovering the mechanism by which oncogenes and tumor suppressors regulate metabolism will allow for designing treatment strategies. This review discusses how several oncogenes and tumor suppressors regulate cellular metabolism, and the current therapeutic findings.

Authors and Affiliations

Muhammad Azharuddin, David Sharon

Keywords

Related Articles

Incidence of Cervical Cancer in Calabar, Nigeria

Aim: The aim of this study is to determine the incidence of cervical cancer among women living in Calabar. Place and Duration of Study: Calabar cancer registry, May to June 2015. Methodology: Data of cervical cancer diag...

The Trend of Colorectal Cancers at Korle-Bu Teaching Hospital: A Retrospective Histopathological Study

Background: Colorectal cancers (CRCs) are common malignancies in Ghana. The aim of the study was to describe the trend and the clinico-pathological characteristics of CRCs in our institution by a retrospective study. Ma...

Sex Hormones, Oestrogen Receptor, Progesterone Receptor and Human Epithelial Receptor 2 Expressions in Pre and Postmenopausal Sub-Saharan African Women with Breast Cancer

Aim: This study was carried out to determine the serum levels of sex hormones and gonadotropins as well as the expression of oestrogen receptor (ER), progesterone receptor (PR) and human epithelial receptor 2 (HER 2) in...

Assessment of Survivin and Lactate Dehydrogenase Isoenzyme in Leukemic Egyptian Patients

Accurate diagnosis and proper monitoring of cancer patients remain important obstacles for successful cancer treatment. The search for cancer biomarkers is carried out in order to quickly identify tumor cells and predict...

Radiation - Induced Sarcoma: A Case Report

Objective: Study the epidemiology, histology, time to onset, treatment and prognosis of radiation induced sarcomas. Observation: We report a case of sarcomas occurring in irradiated area, in a patient treated by external...

Download PDF file
  • EP ID EP243357
  • DOI 10.9734/JCTI/2016/29641
  • Views 85
  • Downloads 0

How To Cite

Muhammad Azharuddin, David Sharon (2016). Role of Oncogenes and Tumor Suppressors in Metabolic Reprogramming and Cancer Therapeutics: A Review. Journal of Cancer and Tumor International, 4(4), 1-27. https://europub.co.uk/articles/-A-243357